2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Vascular Diseases in 1 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, JH | 1 |
| Parveen, A | 1 |
| Do, MH | 1 |
| Lim, Y | 1 |
| Shim, SH | 1 |
| Kim, SY | 1 |
1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Vascular Diseases
| Article | Year |
|---|---|
Lespedeza cuneata protects the endothelial dysfunction via eNOS phosphorylation of PI3K/Akt signaling pathway in HUVECs.
Topics: Cell Survival; Chromones; Human Umbilical Vein Endothelial Cells; Humans; Lespedeza; Morpholines; NG | 2018 |